# Evaluation of the Pharmacokinetic Profile, Pharmacodynamic Effects, Acceptability and Tolerability of an Oral Amiodarone Solution of 15 mg / mL in Children With Supra Ventricular Tachycardia

> **NCT03153072** · PHASE2 · WITHDRAWN · sponsor: **Centre Hospitalier Universitaire, Amiens**

## Conditions studied

- Supraventricular Tachycardia

## Interventions

- **BIOLOGICAL:** Assess the absorption of oral amiodarone

## Key facts

- **NCT ID:** NCT03153072
- **Lead sponsor:** Centre Hospitalier Universitaire, Amiens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2016-09-06
- **Primary completion:** 2017-03-01
- **Final completion:** 2017-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** decision of the investigator
- **Last updated:** 2017-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03153072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03153072, "Evaluation of the Pharmacokinetic Profile, Pharmacodynamic Effects, Acceptability and Tolerability of an Oral Amiodarone Solution of 15 mg / mL in Children With Supra Ventricular Tachycardia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03153072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*